No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹24.5Prev. Close
₹24.62Turnover(Lac.)
₹15.11Day's High
₹24.85Day's Low
₹22.8152 Week's High
₹43.3552 Week's Low
₹20.35Book Value
₹43.16Face Value
₹10Mkt Cap (₹ Cr.)
51.59P/E
11.67EPS
2.11Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 24.43 | 14.9 | 14.9 | 14.95 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 53.75 | 39.49 | 36.97 | 32.19 |
Net Worth | 78.18 | 54.39 | 51.87 | 47.14 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 55.35 | 47 | 34.12 | 28.58 |
yoy growth (%) | 17.76 | 37.72 | 19.39 | 60.68 |
Raw materials | -8.55 | -9.56 | -8.14 | -8.79 |
As % of sales | 15.45 | 20.35 | 23.86 | 30.78 |
Employee costs | -9.99 | -7.58 | -5.49 | -4.34 |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | 4.25 | 4 | 2.83 | 0.78 |
Depreciation | -5.17 | -4.63 | -3.9 | -3.35 |
Tax paid | 0.18 | -0.88 | -0.33 | 0.12 |
Working capital | 8.28 | 4.54 | 4.71 | 8.12 |
Other operating items |
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 17.76 | 37.72 | 19.39 | 60.68 |
Op profit growth | 14.62 | 42.61 | 105.79 | 32.15 |
EBIT growth | 15.34 | 54.58 | 230.95 | 76.34 |
Net profit growth | 42.28 | 24.72 | 175.16 | 96.62 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 53.33 | 46.67 | 45.45 | 52.23 | 51.39 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 53.33 | 46.67 | 45.45 | 52.23 | 51.39 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.44 | 4.8 | 0.04 | 0.04 | 0.1 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,789.95 | 143.56 | 4,30,908.56 | 608.7 | 0.89 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,528.25 | 65.33 | 1,73,929.7 | 756 | 0.46 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,314.25 | 65.57 | 1,47,181.46 | 467 | 0 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,378.9 | 30.36 | 1,12,352.94 | 384.64 | 0.93 | 3,840.92 | 423.38 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,077.25 | 29.72 | 1,09,765.03 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
E D & Wholetime Director
Kalyan Ram Mangipudi
Executive Director / Whole Time Director / CFO
K Sri Kalyan
E D & Wholetime Director
Alangudi Sankaranarayanan
Independent Non Exe. Director
Shyam Sunder Tipparaju
Non Executive Director
Karopadi Shivanand Nayak
Company Sec. & Compli. Officer
Vaishnvi Kiran Ayinampudi
Independent Non Exe. Director
Priya Rajender Goda
Non-Exec & Non-Independent Dir
Satyanarayan Vedula
Survey #349/A Pregnapur Vlge,
Telangana - 502311
Tel: -
Website: http://www.vivobio.com
Email: investors@vivobio.com
1-2-285,
Domalguda, J B Apartments,
Hyderabad - 500 029
Tel: 91-40-27642217 /2763
Website: www.aarthiconsultants.com
Email: info@aarthiconsultants.com
Summary
Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAAL...
Read More
Reports by Vivo Bio Tech Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.